Etoricoxib
Product name:Etoricoxib
CAS No.:202409-33-4
MF:C18H15ClN2O2S
MW:358.84
EINECS No.:682-421-5
Grade:Pharma grade
CAS No.:202409-33-4
MF:C18H15ClN2O2S
MW:358.84
EINECS No.:682-421-5
Grade:Pharma grade
AP374
Quantity

Etoricoxib | ||||

Etoricoxib can reduce pain and inflammation by inhibiting the activity of cyclooxygenase-2 (COX-2)
and reducing the synthesis of inflammatory mediators.
Etoricoxib is effective in relieving the pain and swelling of joints caused by arthritis and gout. Compared
Etoricoxib is effective in relieving the pain and swelling of joints caused by arthritis and gout. Compared
with ordinary NSaids, etocyximab is more selective and has less burden on the body.

Etoricoxib is a non-steroidal anti-inflammatory drug used primarily to treat pain and inflammation, such as
osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and other rheumatoid diseases.



